Archive \ Volume.15 2024 Issue 4

Investigation of the Effect of Topinambur Extract on Cholesterol Levels

Alina Sergeevna Shahova , Evgenii Yurevich Chmutov , Amina Ramazanovna Shkhanokova , Nikita Vitalievich Cherevatov*✉ , Azhbike Emzathanovna Kokozova , Aminat Visingereevna Isaldibirova , Svetlana Vitalyevna Oganyan , Ibragim Ilyasovich Elmurzaev
  1. Department of Therapy, Faculty of Medicine, Stavropol State Medical University, Stavropol, Russia.
  2. Department of Therapy, Pediatric Faculty, North Ossetian State Medical Academy, Vladikavkaz, Russia.

Abstract

This study aimed to investigate the impact of concentrated topinambur extract (CTE) on low-density lipoprotein cholesterol (LDLC) and high-density lipoprotein cholesterol (HDLC) levels in individuals suffering from atherogenic dyslipidemia. The control group adhered to a standard low-calorie diet throughout the treatment period. Meanwhile, the main group followed a modified version of the same diet, incorporating 100 mL of CTE. Our research into the use of CTE in treating dyslipidemia yielded valuable data. The findings indicate that this treatment option is well-tolerated and comparable to standard diet therapy in terms of weight loss. Moreover, we observed a positive impact on blood lipid profile. There was a statistically significant reduction in LDLC levels, while HDLC remained unchanged. This suggests a targeted effect on cholesterol levels without compromising overall cardiovascular health. Furthermore, there were no changes in liver function markers such as aspartate transaminase (AST), alanine aminotransferase (ALT), creatinine, or uric acid among patients receiving CTE.


Downloads: 216
Views: 409

How to cite:
Vancouver
Shahova AS, Chmutov EY, Shkhanokova AR, Cherevatov NV, Kokozova AE, Isaldibirova AV, et al. Investigation of the Effect of Topinambur Extract on Cholesterol Levels. Arch Pharm Pract. 2024;15(4):53-7. https://doi.org/10.51847/DVe6FN5cVU
APA
Shahova, A. S., Chmutov, E. Y., Shkhanokova, A. R., Cherevatov, N. V., Kokozova, A. E., Isaldibirova, A. V., Oganyan, S. V., & Elmurzaev, I. I. (2024). Investigation of the Effect of Topinambur Extract on Cholesterol Levels. Archives of Pharmacy Practice, 15(4), 53-57. https://doi.org/10.51847/DVe6FN5cVU

Download Citation
References
  1. Fu T, Liu H, Shi C, Zhao H, Liu F, Xia Y. Global hotspots and trends of nutritional supplements in sport and exercise from 2000 to 2024: A bibliometric analysis. J Health Popul Nutr. 2024;43(1):146. doi:10.1186/s41043-024-00638-9
  2. Gonzalez Navarro B, Egido Moreno S, Omaña Cepeda C, Estrugo Devesa A, Jane Salas E, Lopez Lopez J. Relationship between oral lichen planus and cardiovascular disease of atherosclerotic origin: Systematic review and meta-analysis. J Clin Med. 2024;13(16):4630. doi:10.3390/jcm13164630
  3. Levochkina ED, Belyaev NG, Guagov AR, Haraziya RS, Lebedeva AA, Vinogradova AS, et al. Biomarkers in predicting myocardial damage in athletes. J Med Pharm Chem Res. 2025;7(2):255-65. doi:10.48309/jmpcr.2025.453328.1195
  4. Belenkov YN, Ilgisonis IS, Khabarova NV, Yu YY. Modern instrumental methods of diagnostics and risk assessment of developing antitumor therapy cardiovasculotoxicity. Kardiologiia. 2024;64(8):3-12. Russian, English. doi:10.18087/cardio.2024.8.n2753
  5. Bielick CG, Arnold CJ, Chu VH. Cardiovascular implantable electronic device infections: A contemporary review. Infect Dis Clin North Am. 2024:S0891-5520(24)00055-2. doi:10.1016/j.idc.2024.07.004
  6. Bashir B, Schofield J, Downie P, France M, Ashcroft DM, Wright AK, et al. Beyond LDL-C: Unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia. Front Cardiovasc Med. 2024;11:1389106. doi:10.3389/fcvm.2024.1389106
  7. Lei S, Liu C, Zheng TX, Fu W, Huang MZ. The relationship of redox signaling with the risk for atherosclerosis. Front Pharmacol. 2024;15:1430293. doi:10.3389/fphar.2024.1430293
  8. Liu YJ, Wang XQ, Zhang G, Zhao Q, Cheng YX, Liu S, et al. The association between food environments and cardiovascular disease outcomes: A systematic review. Heart Lung. 2024;68:359-66. doi:10.1016/j.hrtlng.2024.08.019
  9. Renkens MPL, Coerkamp CF, Witte LS, Sivanesan S, Nurmohamed NS, Westerterp M, et al. Lipoprotein(a) in interventional cardiology: Identifying patients at highest risk of recurrent cardiovascular events through early recognition - A case based review. Expert Rev Cardiovasc Ther. 2024;22(8):353-66. doi:10.1080/14779072.2024.2387678
  10. Milani JGPO, Milani M, Verboven K, Cipriano G Jr, Hansen D. Exercise intensity prescription in cardiovascular rehabilitation: Bridging the gap between best evidence and clinical practice. Front Cardiovasc Med. 2024;11:1380639. doi:10.3389/fcvm.2024.1380639
  11. Lee H, Cho HJ, Han Y, Lee SH. Mid- to long-term efficacy and safety of stem cell therapy for acute myocardial infarction: A systematic review and meta-analysis. Stem Cell Res Ther. 2024;15(1):290. doi:10.1186/s13287-024-03891-1
  12. Rwebembera J, Beaton A. Acute rheumatic fever and rheumatic heart disease: Updates in diagnosis and treatment. Curr Opin Pediatr. 2024;36(5):496-502. doi:10.1097/MOP.0000000000001384
  13. Zitzmann M. Testosterone deficiency and chronic kidney disease. J Clin Transl Endocrinol. 2024;37:100365. doi:10.1016/j.jcte.2024.100365
  14. Sadovoy VV, Selimov MA, Slichedrina TV, Nagdalian AA. Usage of biological active supplements in technology of prophilactic meat products. Res J Pharm Biol Chem Sci. 2016;7(5):1861-5.
  15. Parekumbel Venu A, Rajkumar R, Dinesh Roy D, Thekkumkara Prabhakaran S, Shankar K, Jayapal V, et al. Association of H-FABP with cardiovascular events: A systematic review. J Cardiovasc Thorac Res. 2024;16(2):77-87. doi:10.34172/jcvtr.33039
  16. Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z, et al. Nonalcoholic fatty liver disease and cardiovascular risk: A scientific statement from the American heart association. Arterioscler Thromb Vasc Biol. 2022;42(6):e168-85. doi:10.1161/ATV.0000000000000153
  17. O'Sullivan JW, Raghavan S, Marquez-Luna C, Luzum JA, Damrauer SM, Ashley EA, et al. Polygenic risk scores for cardiovascular disease: A scientific statement from the American heart association. Circulation. 2022;146(8):e93-e118. doi:10.1161/CIR.0000000000001077
  18. Sadovoy VV, Selimov M, Shchedrina T, Nagdalian AA. Nutritional supplement for control of diabetes. J Excip Food Chem. 2017;8352017:1843
  19. Dias KJ, Pignataro RM, Heick JD. Risk factor management for patients with atrial fibrillation in home healthcare. Home Healthc Now. 2024;42(5):301-7. doi:10.1097/NHH.0000000000001274
  20. Chen E, Xi L. Cardiovascular adverse effects of antiviral therapies for COVID-19: Evidence and plausible mechanisms. Acta Pharmacol Sin. 2024. doi:10.1038/s41401-024-01382-w
  21. Sawicka B, Skiba D, Pszczółkowski P, Aslan I, Sharifi-Rad J, Krochmal-Marczak B. Jerusalem artichoke (Helianthus tuberosus L.) as a medicinal plant and its natural products. Cell Mol Biol (Noisy-le-grand). 2020;66(4):160-77.
  22. Wang Y, Zhao Y, Xue F, Nan X, Wang H, Hua D, et al. Nutritional value, bioactivity, and application potential of Jerusalem artichoke (Helianthus tuberosus L.) as a neotype feed resource. Anim Nutr. 2020;6(4):429-37. doi:10.1016/j.aninu.2020.09.001
  23. Krämer I, Goelz R, Gille C, Härtel C, Müller R, Orlikowsky T, et al. Good handling practice of parenterally administered medicines in neonatal intensive care units - Position paper of an interdisciplinary working group. GMS Hyg Infect Control. 2023;18:Doc10. doi:10.3205/dgkh000436
  24. Sinha P, Calfee CS, Delucchi KL. Practitioner's guide to latent class analysis: Methodological considerations and common pitfalls. Crit Care Med. 2021;49(1):e63-e79. doi:10.1097/CCM.0000000000004710
  25. Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: A scientific statement from the American heart association. Circulation. 2023;148(24):1982-2004. doi:10.1161/CIR.0000000000001191
  26. Rajendran A, Minhas AS, Kazzi B, Varma B, Choi E, Thakkar A, et al. Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women. Atherosclerosis. 2023;384:117269. doi:10.1016/j.atherosclerosis.2023
  27. Teo KK, Rafiq T. Cardiovascular risk factors and prevention: A perspective from developing countries. Can J Cardiol. 2021;37(5):733-43. doi:10.1016/j.cjca.2021.02.009
  28. Wan X, Guo H, Liang Y, Zhou C, Liu Z, Li K, et al. The physiological functions and pharmaceutical applications of inulin: A review. Carbohydr Polym. 2020;246:116589. doi:10.1016/j.carbpol.2020.116589
  29. Fernandes A, Nair A, Kulkarni N, Todewale N, Jobby R. Exploring mushroom polysaccharides for the development of novel prebiotics: A review. Int J Med Mushrooms. 2023;25(2):1-10. doi:10.1615/IntJMedMushrooms.2022046837
  30. Frazaei MH, Nouri R, Arefnezhad R, Pour PM, Naseri M, Assar S. A review of medicinal plants and phytochemicals for the management of gout. Curr Rheumatol Rev. 2024;20(3):223-40. doi:10.2174/0115733971268037230920072503
  31. Flori L, Piragine E, Calderone V, Testai L. Role of hydrogen sulfide in the regulation of lipid metabolism: Implications on cardiovascular health. Life Sci. 2024;341:122491. doi:10.1016/j.lfs.2024.122491
  32. Wiciński M, Fajkiel-Madajczyk A, Kurant Z, Liss S, Szyperski P, Szambelan M, et al. Ashwagandha's multifaceted effects on human health: Impact on vascular endothelium, inflammation, lipid metabolism, and cardiovascular outcomes-A review. Nutrients. 2024;16(15):2481. doi:10.3390/nu16152481
  33. Chen L, Chen XW, Huang X, Song BL, Wang Y, Wang Y. Regulation of glucose and lipid metabolism in health and disease. Sci China Life Sci. 2019;62(11):1420-58. doi:10.1007/s11427-019-1563-3
  34. Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab. 2020;42:101092. doi:10.1016/j.molmet.2020.101092
  35. Szántó M, Gupte R, Kraus WL, Pacher P, Bai P. PARPs in lipid metabolism and related diseases. Prog Lipid Res. 2021;84:101117. doi:10.1016/j.plipres.2021.101117
  36. Nurcahyo H, Riyanta AB, Febriyanti R, Sutanto H, Herdwiani W. Hypolipidemic activity of Ceciwis ethanol extract on wistar rats induced by high fat in vivo. J Adv Pharm Educ Res. 2023;13(1):100-4.
  37. Awasthi A, Bigoniya P, Gupta B. Physicochemical properties and in vitro anti-obesity potential of anethum graveolens (Dill) seed cake. Int J Pharm Res Allied Sci. 2024;13(2):48-57.
  38. Alkattaby LA. Biophysical effects of zinc oxide nanoparticles in alleviate lipid and serum glucose. J Biochem Technol. 2023;14(2):134-41.
  39. Baharith AA, Alharbi ON. Prevalence of risky behaviors among patients attending diabetes and endocrinology clinics in KFAFH 2022. Pharmacophore. 2023;14(1):100-10.
  40. Mukhametova Y, Tokhiriyon B, Poznyakovsky V, Pastushkova E, Toshev A. Supplements with polyprenols: Assessment of the Russian market potential. Int J Pharm Res Allied Sci. 2023;12(2):128-32.
  41. Ostashchenko T, Lutska A, Tomchuk V, Koval A, Solomennyi A, Snizhynskyi S, et al. Current trends in the development of the pharmaceutical market in Ukraine. Pharmacophore. 2023;14(4):64-7.
  42. Smalls T, Hailemeskel B. Metformin use review in non-alcoholic fatty liver disease (NFLDA) and students survey. Int J Pharm Phytopharmacol Res. 2024;14(1):8-15.

 

 

 


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.